Acetazolamide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-349 -
Package NDC
62332-349-31 -
Package NDC
62332-349-91 -
Application number
ANDA210423 -
SPL ID
5e12d289-e62f-4b85-a419-ec24a39049ba -
SPL set ID
43231abb-2a5d-44ab-b3e6-7564a1131ac5 -
UNII
O3FX965V0I -
RxCUI
562524
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- Acetazolamide
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Acetazolamide",
"splId": "5e12d289-e62f-4b85-a419-ec24a39049ba",
"labels": [
{
"setId": "43231abb-2a5d-44ab-b3e6-7564a1131ac5",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43231abb-2a5d-44ab-b3e6-7564a1131ac5",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=43231abb-2a5d-44ab-b3e6-7564a1131ac5"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-349-31)",
"package_ndc": "62332-349-31",
"identifierStatus": "well-formed",
"marketing_start_date": "20190220"
},
{
"sample": false,
"description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-349-91)",
"package_ndc": "62332-349-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20190220"
}
],
"productId": "62332-349_5e12d289-e62f-4b85-a419-ec24a39049ba",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "62332-349",
"deaSchedule": null,
"genericName": "Acetazolamide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ACETAZOLAMIDE",
"strength": "500 mg/1"
}
],
"applicationNumber": "ANDA210423",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190220",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175517",
"N0000000235",
"M0020790"
],
"upc": [
"0362332349319"
],
"unii": [
"O3FX965V0I"
],
"rxcui": [
"562524"
],
"spl_set_id": [
"43231abb-2a5d-44ab-b3e6-7564a1131ac5"
],
"pharm_class_cs": [
"Sulfonamides [CS]"
],
"pharm_class_epc": [
"Carbonic Anhydrase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Carbonic Anhydrase Inhibitors [MoA]"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-349_5e12d289-e62f-4b85-a419-ec24a39049ba"